FINANCIAL ASSISTANCE
No matter what type of health insurance you have, there may be support to help you afford BRIUMVI. Options may be available for you even if you have no health insurance at all.
Download a brochure to learn more
FINANCIAL ASSISTANCE
No matter what type of health insurance you have, there may be support to help you afford BRIUMVI. Options may be available for you even if you have no health insurance at all.
Download a brochure to learn more
FINANCIAL ASSISTANCE
No matter what type of health insurance you have, there may be support to help you afford BRIUMVI. Options may be available for you even if you have no health insurance at all.
Download a brochure to learn more
What is the BRIUMVI Copay Assistance Program?
Treatment Costs
Eligible patients may pay as little as $0 copay per BRIUMVI treatment up to the annual maximum of $20,000
Infusion and Administration Costs
Eligible patients who have out-of-pocket costs may be covered up to $550 for the first infusion and then up to $350 per infusion thereafter
You may be eligible if you…
- Have commercial insurance
- Are 18 years of age or older
Click here for full BRIUMVI Copay Program Terms and Conditions
OTHER FINANCIAL ASSISTANCE OPTIONS
If you are not eligible for the BRIUMVI Copay Assistance Program, you may qualify for these other financial assistance options.
BRIUMVI Patient Assistance Program
If you do not have insurance or are underinsured and meet certain financial eligibility criteria, you may qualify for the BRIUMVI Patient Assistance Program. You can ask your Case Manager for more information about the BRIUMVI Patient Assistance Program.
Third-party charitable organizations†
If you are not eligible for any BRIUMVI financial assistance programs, there are third-party charitable organizations that may be able to help.
BRIUMVI Patient Support
Discover a flexible program designed to support the treatment journey in a way that works best for you.
JOIN THE THOUSANDS WHO ARE TAKING ON RMS WITH BRIUMVI
Discover how BRIUMVI is impacting real people with RMS.
Hear from people who have included it in their RMS treatment journey.
JOIN THE THOUSANDS WHO ARE TAKING ON RMS WITH BRIUMVI
Discover how BRIUMVI is impacting real people with RMS.
Hear from people who have included it in their RMS treatment journey.
JOIN THE THOUSANDS WHO ARE TAKING ON RMS WITH BRIUMVI
Discover how BRIUMVI is impacting real people with RMS.
Hear from people who have included it in their RMS treatment journey.
People featured on this page have been compensated by TG Therapeutics for their time.
INDICATION AND IMPORTANT
SAFETY INFORMATION
Who should not receive BRIUMVI?
What is the most important information I should know about BRIUMVI?
- fever
- chills
- headache
- flu-like symptoms
- fast heartbeat
- hives
- itchy skin
- dizziness
- feeling faint
- swelling of tongue or throat
- trouble breathing
- wheezing
- nausea
- abdominal pain
- throat irritation
- redness of the face or skin
These infusion reactions can happen over 24 hours after your infusion. It is important that you call your healthcare provider right away if you get any of the signs or symptoms listed above after each infusion. If you get an infusion reaction, your healthcare provider may need to stop or slow down the rate of your infusion.
- Infection:
- Infections are a common side effect, and upper respiratory tract infections are one of the most common side effects of BRIUMVI. BRIUMVI increases your risk of getting infections caused by bacteria or viruses that may be life-threatening or cause death. Tell your healthcare provider if you have an infection or have any of the following signs of infection including fever, chills, a cough that does not go away, or painful urination. Your healthcare provider should delay your treatment with BRIUMVI until your infection is gone.
- Hepatitis B virus (HBV) reactivation: Before starting treatment with BRIUMVI, your healthcare provider will do blood tests to check for hepatitis B viral infection. If you have ever had hepatitis B virus infection, the hepatitis B virus may become active again during or after treatment with BRIUMVI. Hepatitis B virus becoming active again (called reactivation) may cause serious liver problems including liver failure or death. Your healthcare provider will monitor you if you are at risk for hepatitis B virus reactivation during treatment and after you stop receiving BRIUMVI.
- Weakened immune system: BRIUMVI taken before or after other medicines that weaken the immune system could increase your risk of getting infections.
- Progressive Multifocal Leukoencephalopathy (PML): PML may happen with BRIUMVI. PML is a rare, serious brain infection caused by a virus that may get worse over days or weeks. PML can result in death or severe disability. Tell your healthcare provider right away if you have any new or worsening neurologic signs or symptoms. These symptoms may include weakness on one side of your body, loss of coordination in arms and legs, vision problems, changes in thinking and memory which may lead to confusion, and personality changes.
- Low immunoglobulins: BRIUMVI may cause a decrease in some types of antibodies. Your healthcare provider will do blood tests to check your blood immunoglobulin levels.
Before receiving BRIUMVI, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of BRIUMVI?
Indication
